VIVIMUSTA J Code: J9056

Drug & Product Overview

HCPCS Descriptor Injection, bendamustine hydrochloride (vivimusta), 1 mg

HCPCS Added Date July 1, 2023

Manufacturer Azurity Pharmaceuticals

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Multi-Dose

Dosage Form Injection

About VIVIMUSTA

Vivimusta is a medication aligned to the HCPCS J Code: J9056 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Azurity Pharmaceuticals.

According to CMS Drug Use Information: This medication is used to treat certain types of cancer. Bendamustine belongs to a class of cancer chemotherapy drugs known as alkylating agents. It works by killing cancer cells or slowing their growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
24338-0270-01	Vivimusta	Azurity Pharmaceuticals, Inc.	100	100 MG / 4 ML
71225-0120-01	Vivimusta	Slayback Pharma LLC	100	100 MG / 4 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

VIVIMUSTA Pricing & Reimbursement

J9056 Private Payer Reimbursement

$32.65 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Bendamustine Hydrochloride 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9033	Generic Code (Multiple Manufacturers)	Bendamustine Hydrochloride	Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
J9034	Teva	Bendamustine Hydrochloride	Injection, bendamustine hcl (bendeka), 1 mg
J9036	Generic Code (Multiple Manufacturers)	Bendamustine Hydrochloride	Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
J9056	Azurity Pharmaceuticals	Bendamustine Hydrochloride	Injection, bendamustine hydrochloride (vivimusta), 1 mg

VIVIMUSTA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 6.58%

Avg. Days to File 6.7days

Avg. Days to Pay 22.1days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9056 claims analytics on FocalPoint →

VIVIMUSTA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

CMS does not include Vivimusta (J9056) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9056. Wastage billing guide →

VIVIMUSTA Medically Unlikely Edits (MUE)

The most billing units of J9056 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

360 units / day

= 360 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

VIVIMUSTA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma

Drug Class

Alkylating Activity [MoA]Alkylating Drug [EPC]

Frequently Asked Questions

Is there an available Vivimusta billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for VIVIMUSTA.

Are there any available Vivimusta patient assistance programs?

VIVIMUSTA patient assistance information can be found through SLAYBACK PHARMA. Visit Here →

Where can I find Vivimusta prescribing information?

VIVIMUSTA prescribing information can be found at the link below: Visit Here →

Where can I find Vivimusta side effect information?

Our team has not yet identified a source of side effects information for VIVIMUSTA. Please check back in a few weeks.

Does billing VIVIMUSTA require JZ/JW wastage modifiers?

CMS does not include VIVIMUSTA (J9056) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9056. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.